Riamilovir sodium hydrate - CAS# 928659-17-0 0072 PMID: 31826639

PMID: 31826639

[Epub ahead of print] PubMed PMID: 24276460

AC-55541 was well absorbed when administered intraperitoneally to rats

4SC-202 shows a broad anti-proliferative activity towards human cancer cell lines with a mean IC50 of 0

also known as GSK2118436

Riamilovir sodium hydrate - CAS# 928659-17-0 0072 PMID: 31826639Riamilovir sodium hydrate, CAS No. 928659 17 0, also known as Triazavirin, is an antiviral drug candidate. Tiazavirin is a broad spectrum antiviral drug developed in Russia. It has a novel triazolotriazine core, which represents a new structural class of non nucleoside antiviral drugs. It was originally developed as a potential treatment for pandemic influenza strains such as H5N1, and most of the testing that has been done has focused on its anti